⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4372384 | 0.82 | ALDH1A1 (0.60) | — | |
| SCHEMBL14181588 | 0.80 | — | — | |
| SCHEMBL75810 | 0.80 | — | — | |
| SCHEMBL1568287 | 0.80 | — | — | |
| SCHEMBL14198852 | 0.78 | — | — | |
| Hydrochloric Acid SCHEMBL8191621 | 0.78 | GMNN (0.55) | — | |
| Hydrochloric Acid SCHEMBL5886523 | 0.78 | — | — | |
| Hydrochloric Acid SCHEMBL18547978 | 0.78 | GMNN (0.55) | — | |
| Hydrochloric Acid SCHEMBL4318121 | 0.78 | — | — | |
| SCHEMBL13525318 | 0.77 | ALDH1A1 (0.45) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 73 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250079161-A1 | DEPOSITION OF ORGANIC MATERIAL | ASM IP HOLDING B.V. (NL) | 2025-03-06 | — | — | US | claimed |
| CN-119530765-A | Deposition of organic materials | ASM IP私人控股有限公司 | 2025-02-28 | — | — | CN | claimed |
| CN-115717328-A | Light composite casing material and preparation method thereof | 深圳市东霖科技有限公司 | 2023-02-28 | — | — | CN | claimed |
| CN-1784212-A | Oral care methods and products | DMI BIOSCIENCES INC (US) | 2006-06-07 | — | — | CN | claimed |
| US-20260146045-A1 | COMPOSITIONS AND USES THEREOF | SOLVE THERAPEUTICS, INC. (US) | 2026-05-28 | — | — | US | disclosed |
| US-20260138990-A1 | TRICYCLIC FUSED IMIDAZOLE COMPOUNDS AS CD38 MODULATORS AND USES THEREOF | AEOVIAN PHARMACEUTICALS INC (US) | 2026-05-21 | — | — | US | disclosed |
| US-12624052-B2 | KRAS modulators and uses thereof | QUANTA THERAPEUTICS, INC. (US) | 2026-05-12 | — | — | US | disclosed |
| EP-4504883-B1 | FABRIC TREATMENT COMPOSITIONS WITH ANTIOXIDANT MULTIMERS | PROCTER & GAMBLE (US) | 2026-04-29 | — | — | EP | disclosed |
| US-20260102506-A1 | COMPOSITIONS AND USES THEREOF | SOLVE THERAPEUTICS INC (US) | 2026-04-16 | — | — | US | disclosed |
| EP-4713020-A2 | DRUG-LINKERS AND DRUG CONJUGATES | Solve Therapeutics, Inc. (US) | 2026-03-25 | — | — | EP | disclosed |
| EP-4702026-A1 | TRICYCLIC FUSED IMIDAZOLE COMPOUNDS AS CD38 MODULATORS AND USES THEREOF | Aeovian Pharmaceuticals, Inc. (US) | 2026-03-04 | — | — | EP | disclosed |
| EP-4680609-A1 | KRAS MODULATORS AND USES THEREOF | Quanta Therapeutics, Inc. (US) | 2026-01-21 | — | — | EP | disclosed |
| CN-101970012-A | Drug carrier | NITTO DENKO CORP | 2011-02-09 | — | — | CN | disclosed |
| CN-1646174-B | Controllably degradable polymeric biomolecule or drug carrier and method of synthesizing said carrier | NITTO DENKO CORP | 2010-12-08 | — | — | CN | disclosed |
| EP-1735393-A4 | CLEAR COATING COMPOSITION AND CLEAR COATING FILM FORMATION METHOD | NIPPON PAINT CO LTD (JP) | 2007-09-05 | — | — | EP | disclosed |
| EP-1735393-A1 | CLEAR COATING COMPOSITION AND CLEAR COATING FILM FORMATION METHOD | Nippon Paint Co., Ltd. (JP) | 2006-12-27 | — | — | EP | disclosed |
| CN-1784212-A | Oral care methods and products | DMI BIOSCIENCES INC (US) | 2006-06-07 | — | — | CN | disclosed |
| WO-2005100492-A1 | CLEAR COATING COMPOSITION AND CLEAR COATING FILM FORMATION METHOD | NIPPON PAINT CO., LTD. (JP) | 2005-10-27 | — | — | WO | disclosed |
| CN-1646174-A | Controllably degradable polymeric biomolecule or drug carrier and method of synthesizing said carrier | NITTO DENKO CORP (JP) | 2005-07-27 | — | — | CN | disclosed |
| EP-0737726-B1 | One-component, thermosetting resin composition for coating use | NIPPON PAINT CO LTD (JP) | 1999-07-14 | — | — | EP | disclosed |